Rob Dhoble

Rob is a communications expert on the expanding science of the human endocannabinoid system (ECS), establishing the first-ever major network education and training advisory in the Cannabis and Cannabinoid Medicines space, Havas ECS (Endocannabinoid Science). Rob can speak to the cultural, political, regulatory, and commercial dimensions in the use of hemp- and marijuana-derived, self-care and medical care cannabinoid products. These include prescription cannabinoid medicines on the market, both in the US and globally, and in development, for a wide range of ECS-related medical conditions, including anxiety, seizures, PTSD, opioid use disorder, autism, cancer, multiple sclerosis, Crohn’s Disease, insomnia, depression, and chronic pain.